To further elucidate the molecular mechanisms of BCAP31 in promoting breast cancer development, binding partners of BCAP31 were purified using immune affinity purification 24 and resolved using liquid chromatography-tandem mass spectrometry (LC-MS/MS) (Figure 4A). Here, BCAP31 is linked to breast carcinoma.